Aurobindo Pharma
- All
- News
- Videos
-
Probe Agency Attaches Assets Over Rs 115 Crore Of 2 Approvers In Delhi Liquor Policy Case
The Enforcement Directorate (ED) has attached assets worth more than Rs 115 crore of two of its approvers -- TDP's Lok Sabha poll candidate Magunta Sreenivasulu Reddy's businessman son Raghav Magunta and Aurobindo Pharma promoter Sarath Chandra Reddy
-
K Kavitha "Threatened" Pharma Firm Boss To Pay Rs 25 Crore To AAP: CBI To Court
CBI told a special court here that BRS leader K Kavitha allegedly "threatened" Aurobindo Pharma promoter Sharath Chandra Reddy to pay an amount of Rs 25 crore to the AAP for the five retail zones allotted to his firm under the Delhi excise policy.
-
This Firm With Liquor Policy Case Link Bought Rs 52 Crore Electoral Bonds
Aurobindo Pharma, in total, bought electoral bonds worth ₹52 crore, more than half of which was given to the ruling Bharatiya Janata Party (BJP).
-
Delhi Liquor Scam: Aviation Firm Denies Transporting Cash Or Liquor
JetSetGo owner Kanika Tekriwal Reddy said in a statement today that reports that the planes of the chartered flight service provider were involved in the alleged scam are false
-
Aurobindo Pharma Stock Falls Nearly 7% In Early Trade, Hits 52-Week Low After Q2 Results
Shares of Aurobindo Pharma on Monday fell nearly 7 per cent in early trade after the company reported a 41 per cent decline in its consolidated net profit for the second quarter ended September 30, 2022.
-
Aurobindo Pharma's Second Quarter Net Profit Falls 41% To Rs 409 Crore
Aurobindo Pharma has posted a decline of 41 per cent in its net profit to Rs 409 crore in the quarter ended September against Rs 697 crore in the year-ago period.
-
Aurobindo Pharma Shares Gain 3%, A Day After Hitting A 52-Week Low
Shares of Aurobindo Pharma rose nearly 3 per cent in early trade on Friday, a day after touching a 52-week low.
-
In Delhi Liquor Policy Case, Boss Of Hyderabad Pharma Firm Is Arrested
A top official of a pharma company has been arrested by the Enforcement Directorate in connection with its money laundering probe into alleged irregularities in the now-scrapped Delhi excise policy.
-
Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
-
Dr Reddy's, Cipla, Aurobindo Units Recall Products From US Market
Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration.
-
Stocks To Watch: Nazara Tech, Wipro, Aurobindo Pharma, Cipla
The domestic stock indices are likely to trade lower on Monday, taking cues from the global markets.
-
BCCI Expecting 2 New IPL Franchises To Go For Rs. 7000-10,000 Crore With Adani Group, Aurobindo Pharma, RPSG In Fray: Report
According to a report, the BCCI is also allowing a consortium of up to three companies or individuals to bid for a IPL franchise.
-
Stocks To Watch: Tata Steel, Hero MotoCorp, Ashok Leyland, Aurobindo Pharma
Tata Steel reported a net profit of Rs 9,768 crore in the June quarter compared to a net loss of Rs 4,648 crore in the corresponding quarter last year
-
Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
Aurobindo Pharma Share Price: On Tuesday, Aurobindo Pharma opened on the BSEat Rs 1,000,inching to an intra day high of Rs 1,007.95, and an intra day low of Rs 959.90, so far.
-
Stocks To Watch: TCS, Aurobindo Pharma, Titan
Aurobindo Pharma reported an over four-fold jump in consolidated net profit to Rs 2,946.32 crore for the quarter ended December 2020, mainly on account of exceptional gains
-
Probe Agency Attaches Assets Over Rs 115 Crore Of 2 Approvers In Delhi Liquor Policy Case
The Enforcement Directorate (ED) has attached assets worth more than Rs 115 crore of two of its approvers -- TDP's Lok Sabha poll candidate Magunta Sreenivasulu Reddy's businessman son Raghav Magunta and Aurobindo Pharma promoter Sarath Chandra Reddy
-
K Kavitha "Threatened" Pharma Firm Boss To Pay Rs 25 Crore To AAP: CBI To Court
CBI told a special court here that BRS leader K Kavitha allegedly "threatened" Aurobindo Pharma promoter Sharath Chandra Reddy to pay an amount of Rs 25 crore to the AAP for the five retail zones allotted to his firm under the Delhi excise policy.
-
This Firm With Liquor Policy Case Link Bought Rs 52 Crore Electoral Bonds
Aurobindo Pharma, in total, bought electoral bonds worth ₹52 crore, more than half of which was given to the ruling Bharatiya Janata Party (BJP).
-
Delhi Liquor Scam: Aviation Firm Denies Transporting Cash Or Liquor
JetSetGo owner Kanika Tekriwal Reddy said in a statement today that reports that the planes of the chartered flight service provider were involved in the alleged scam are false
-
Aurobindo Pharma Stock Falls Nearly 7% In Early Trade, Hits 52-Week Low After Q2 Results
Shares of Aurobindo Pharma on Monday fell nearly 7 per cent in early trade after the company reported a 41 per cent decline in its consolidated net profit for the second quarter ended September 30, 2022.
-
Aurobindo Pharma's Second Quarter Net Profit Falls 41% To Rs 409 Crore
Aurobindo Pharma has posted a decline of 41 per cent in its net profit to Rs 409 crore in the quarter ended September against Rs 697 crore in the year-ago period.
-
Aurobindo Pharma Shares Gain 3%, A Day After Hitting A 52-Week Low
Shares of Aurobindo Pharma rose nearly 3 per cent in early trade on Friday, a day after touching a 52-week low.
-
In Delhi Liquor Policy Case, Boss Of Hyderabad Pharma Firm Is Arrested
A top official of a pharma company has been arrested by the Enforcement Directorate in connection with its money laundering probe into alleged irregularities in the now-scrapped Delhi excise policy.
-
Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
-
Dr Reddy's, Cipla, Aurobindo Units Recall Products From US Market
Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration.
-
Stocks To Watch: Nazara Tech, Wipro, Aurobindo Pharma, Cipla
The domestic stock indices are likely to trade lower on Monday, taking cues from the global markets.
-
BCCI Expecting 2 New IPL Franchises To Go For Rs. 7000-10,000 Crore With Adani Group, Aurobindo Pharma, RPSG In Fray: Report
According to a report, the BCCI is also allowing a consortium of up to three companies or individuals to bid for a IPL franchise.
-
Stocks To Watch: Tata Steel, Hero MotoCorp, Ashok Leyland, Aurobindo Pharma
Tata Steel reported a net profit of Rs 9,768 crore in the June quarter compared to a net loss of Rs 4,648 crore in the corresponding quarter last year
-
Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
Aurobindo Pharma Share Price: On Tuesday, Aurobindo Pharma opened on the BSEat Rs 1,000,inching to an intra day high of Rs 1,007.95, and an intra day low of Rs 959.90, so far.
-
Stocks To Watch: TCS, Aurobindo Pharma, Titan
Aurobindo Pharma reported an over four-fold jump in consolidated net profit to Rs 2,946.32 crore for the quarter ended December 2020, mainly on account of exceptional gains
